195 related articles for article (PubMed ID: 31921159)
1. Contextual Cell Death in Adaptive Immunity: Selecting a Winning Response.
Herbert A
Front Immunol; 2019; 10():2898. PubMed ID: 31921159
[TBL] [Abstract][Full Text] [Related]
2. Both APRIL and antibody-fragment-based CAR T cells for myeloma induce BCMA downmodulation by trogocytosis and internalization.
Camviel N; Wolf B; Croce G; Gfeller D; Zoete V; Arber C
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36323436
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome and adaptive immunity in schizophrenia.
Agorastos A; Bozikas VP
Psychiatriki; 2019; 30(3):189-192. PubMed ID: 31685450
[TBL] [Abstract][Full Text] [Related]
4. Nano-Pulse Stimulation induces immunogenic cell death in human papillomavirus-transformed tumors and initiates an adaptive immune response.
Skeate JG; Da Silva DM; Chavez-Juan E; Anand S; Nuccitelli R; Kast WM
PLoS One; 2018; 13(1):e0191311. PubMed ID: 29324830
[TBL] [Abstract][Full Text] [Related]
5. Cross-Activation of Hemichannels/Gap Junctions and Immunoglobulin-Like Domains in Innate-Adaptive Immune Responses.
Meng JH; Chen CX; Ahmadian MR; Zan H; Luo KJ; Jiang JX
Front Immunol; 2022; 13():882706. PubMed ID: 35911693
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
7. Cell death recognition model for the immune system.
Sun E
Med Hypotheses; 2008; 70(3):585-96. PubMed ID: 17681705
[TBL] [Abstract][Full Text] [Related]
8. The control of adaptive immune responses by the innate immune system.
Schenten D; Medzhitov R
Adv Immunol; 2011; 109():87-124. PubMed ID: 21569913
[TBL] [Abstract][Full Text] [Related]
9. The Role of Trogocytosis in the Modulation of Immune Cell Functions.
Miyake K; Karasuyama H
Cells; 2021 May; 10(5):. PubMed ID: 34069602
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway.
Shen C; Zhang Z; Tian Y; Li F; Zhou L; Jiang W; Yang L; Zhang B; Wang L; Zhang Y
BMC Med; 2021 Nov; 19(1):283. PubMed ID: 34819055
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis.
Nedeva C
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356636
[TBL] [Abstract][Full Text] [Related]
12. RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes.
Aida K; Nishida Y; Tanaka S; Maruyama T; Shimada A; Awata T; Suzuki M; Shimura H; Takizawa S; Ichijo M; Akiyama D; Furuya F; Kawaguchi A; Kaneshige M; Itakura J; Fujii H; Endo T; Kobayashi T
Diabetes; 2011 Mar; 60(3):884-9. PubMed ID: 21289206
[TBL] [Abstract][Full Text] [Related]
13. CD103
Kuhn NF; Lopez AV; Li X; Cai W; Daniyan AF; Brentjens RJ
Nat Commun; 2020 Dec; 11(1):6171. PubMed ID: 33268774
[TBL] [Abstract][Full Text] [Related]
14. A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.
Liang J; Fang D; Gumin J; Najem H; Sooreshjani M; Song R; Sabbagh A; Kong LY; Duffy J; Balyasnikova IV; Pollack SM; Puduvalli VK; Heimberger AB
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831427
[TBL] [Abstract][Full Text] [Related]
15. Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells.
Morandi F; Yazdanifar M; Cocco C; Bertaina A; Airoldi I
Cells; 2020 Jul; 9(8):. PubMed ID: 32707982
[TBL] [Abstract][Full Text] [Related]
16. Evolution of adaptive immune recognition in jawless vertebrates.
Saha NR; Smith J; Amemiya CT
Semin Immunol; 2010 Feb; 22(1):25-33. PubMed ID: 20056434
[TBL] [Abstract][Full Text] [Related]
17. Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector.
Smith EL; Staehr M; Masakayan R; Tatake IJ; Purdon TJ; Wang X; Wang P; Liu H; Xu Y; Garrett-Thomson SC; Almo SC; Riviere I; Liu C; Brentjens RJ
Mol Ther; 2018 Jun; 26(6):1447-1456. PubMed ID: 29678657
[TBL] [Abstract][Full Text] [Related]
18. Targeting toll-like receptors on T cells as a therapeutic strategy against tumors.
Ding R; Jiao A; Zhang B
Int Immunopharmacol; 2022 Jun; 107():108708. PubMed ID: 35306281
[TBL] [Abstract][Full Text] [Related]
19. Stress proteins and the immune response.
Moseley P
Immunopharmacology; 2000 Jul; 48(3):299-302. PubMed ID: 10960671
[TBL] [Abstract][Full Text] [Related]
20. Toll-Like Receptors in Adaptive Immunity.
Kumar V
Handb Exp Pharmacol; 2022; 276():95-131. PubMed ID: 34510306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
